Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 12.22% vs 4.28% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is 17.02% vs 64.48% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is 17.97% vs 19.69% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is -17.70% vs -7.72% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
Compare Quarterly Results Of Jubilant Pharmo With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 3.46% vs -1.46% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 12.22% vs 4.28% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 16.91% vs -33.01% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 17.02% vs 64.48% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 17.89% vs -16.16% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 17.97% vs 19.69% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 2.45% vs -7.02% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -17.70% vs -7.72% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






